Clopidogrel Bisulfate
- CAS No.
- 120202-66-6
- Chemical Name:
- Clopidogrel Bisulfate
- Synonyms
- CLOPIDOGREL BISULPHATE;Clopidogrel hydrogen sulfate;PLAVIX;CLOPIDOGREL HYDROGEN SULPHATE;CLOPIDOGREL SULFATE;(S)-(+)-Clopidogrel Sulfate;Clopidogrel Bisulfate (Form 2);Stroka;opidog;Iscover
- CBNumber:
- CB1341210
- Molecular Formula:
- C16H16ClNO2S.H2O4S
- Molecular Weight:
- 419.9
- MDL Number:
- MFCD00876395
- MOL File:
- 120202-66-6.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Clopidogrel for system suitability European Pharmacopoeia (EP) Reference Standard | Y0001334 | 70 mg | $241 |
| Clopidogrel hydrogen sulfate European Pharmacopoeia (EP) Reference Standard | Y0001333 | 60 mg | $166 |
| Clopidogrel Bisulfate Pharmaceutical Secondary Standard; Certified Reference Material | PHR1431 | 1g | $225 |
| Clopidogrel bisulfate United States Pharmacopeia (USP) Reference Standard | 1140430 | 125mg | $1810 |
| (S)-(+)-Clopidogrel Sulfate >98.0%(HPLC)(N) | C2556 | 1g | $119 |
| More product size | |||
| Melting point | 174-176°C |
|---|---|
| storage temp. | 2-8°C |
| solubility | DMSO: ~26 mg/mL |
| form | solid |
| color | white |
| optical activity | [α]/D +54 to +70°, c = 0.5 in methanol |
| BRN | 9967887 |
| BCS Class | 2 |
| Major Application | pharmaceutical (small molecule) |
| InChI | InChI=1/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)/t15-;/s3 |
| InChIKey | FDEODCTUSIWGLK-RSAXXLAASA-N |
| SMILES | S(O)(O)(=O)=O.[C@@H](C1C=CC=CC=1Cl)(N1CCC2SC=CC=2C1)C(=O)OC |&1:5,r| |
| CAS DataBase Reference | 120202-66-6(CAS DataBase Reference) |
| FDA UNII | 08I79HTP27 |
| NCI Drug Dictionary | clopidogrel bisulfate |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |    GHS07,GHS05,GHS09 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H335-H411-H362-H314 | |||||||||
| Precautionary statements | P201-P260-P263-P264-P270-P308+P313-P260-P264-P280-P301+P330+P331-P303+P361+P353-P363-P304+P340-P310-P321-P305+P351+P338-P405-P501 | |||||||||
| Safety Statements | 22-24/25 | |||||||||
| RIDADR | 1759 | |||||||||
| WGK Germany | 3 | |||||||||
| HazardClass | 8 | |||||||||
| PackingGroup | II | |||||||||
| HS Code | 29349990 | |||||||||
| Storage Class | 8A - Combustible corrosive hazardous materials | |||||||||
| Hazard Classifications | Aquatic Chronic 2 Eye Dam. 1 Skin Corr. 1B |
|||||||||
| REACH Registrations | Active | |||||||||
| NFPA 704 |
|
Clopidogrel Bisulfate price More Price(73)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | Y0001334 | Clopidogrel for system suitability European Pharmacopoeia (EP) Reference Standard | 120202-66-6 | 70 mg | $241 | 2026-04-30 | Buy |
| Sigma-Aldrich | Y0001333 | Clopidogrel hydrogen sulfate European Pharmacopoeia (EP) Reference Standard | 120202-66-6 | 60 mg | $166 | 2026-04-30 | Buy |
| Sigma-Aldrich | PHR1431 | Clopidogrel Bisulfate Pharmaceutical Secondary Standard; Certified Reference Material | 120202-66-6 | 1g | $225 | 2026-04-30 | Buy |
| Sigma-Aldrich | 1140430 | Clopidogrel bisulfate United States Pharmacopeia (USP) Reference Standard | 120202-66-6 | 125mg | $1810 | 2026-04-30 | Buy |
| TCI Chemical | C2556 | (S)-(+)-Clopidogrel Sulfate >98.0%(HPLC)(N) | 120202-66-6 | 1g | $119 | 2026-04-30 | Buy |
Clopidogrel Bisulfate Chemical Properties,Uses,Production
Description
(S)-(+)-Clopidogrel is the functional enantiomer of clopidogrel and a prodrug whose thiol metabolite antagonizes purine binding to the platelet purinergic receptor P2Y12 (Ki = 316 nM in human platelets). It is metabolized by the cytochrome P450 (CYP) isoform CYP2C19 in rat liver and inhibits ADP-induced platelet aggregation ex vivo. Formulations containing (S)-(+)-clopidogrel have been used in combination with aspirin to prevent vascular ischemic events in patients with acute coronary syndromes.
Chemical Properties
Off-White Solid
Originator
Iscover,Bristol-Myers
Uses
An irreversible inhibitor of P2Y12.
Uses
Used as an antithrombotic.
Uses
Clopidogrel Bisulfate is an oral, thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Manufacturing Process
Levo-rotatory ammonium camphor-10-sulfonate is dissolved in a minimum of
water and applied to the column of Amberlite IRN-77 resin. Elution is carried
out with water. The eluted fractions containing the levo-rotatory camphor-10-
sulfonic acid are lyophilized, melting point 198°C.
32 g (0.0994 mole) of racemic methyl-α-5-(4,5,6,7-tetrahydro-thieno(3,2-
c)pyridyl)(2-chlorophenyl)-acetate are dissolved in 150 ml of acetone. 9.95 g
(0.0397 mole) of levo-rotatory camphor-10-sulfonic acid monohydrate are
added. The clear solution is left to stand at room temperature. After 48 hours
the reaction mixture is concentrated to 50 ml and left to stand at room
temperature for 24 hours. The obtained camphor-10-sulfonic acid salt of
methyl-α-5-(4,5,6,7-tetrahydro-thieno(3,2-c)pyridyl)(2-chlorophenyl)-acetate
(SR 25990) are filtered off, washed with acetone and dried (yield: 55% on the
basis of the starting racemate), melting point 165°C, [α]D20=+24.67 (c=1.58
g/100 ml; methanol). The crystals obtained above are redissolved in the
minimum of boiling acetone (50 ml). The crystals obtained after cooling are
filtered off, washed with acetone and dried (yield: 88%), m.p. 165°C,
[α]D20=+24.75 (c=1.68 g/100 ml; methanol).
12 g (0.022 mole) of the pure camphor-10-sulfonic acid salt of methyl-α-5-
(4,5,6,7-tetrahydro-thieno(3,2-c)pyridyl)(2-chlorophenyl)-acetate are
dissolved in a minimum of water. After cooling to 5°C, the aqueous solution
obtained is made alkaline with a saturated aqueous solution of sodium
hydrogen carbonate. The alkaline aqueous phase is extracted with
dichloromethane. The organic extracts are dried over anhydrous sodium
sulfate. On evaporation of the solvent a colorless oil of dextro-rotatory
methyl-α-5-(4,5,6,7-tetrahydro-thieno(3,2-c)pyridyl)(2-chlorophenyl)-acetate
is obtained (quantitative yield). Oil, [α]D20=+51.52 (c=1.61 g/100 ml;
methanol).
800 ml of a saturated aqueous solution of sodium bicarbonate are added to a
suspension of 200 g of SR 25990 in 800 ml of dichloromethane. After vigorous
shaking, the organic phase is separated, dried over sodium sulfate and the
solvent is removed under reduced pressure. The residue is dissolved in 500 ml
of ice-cold acetone and 20.7 ml of concentrated sulfuric acid (93.64%) are
added drop-wise. The precipitate formed is isolated by filtration and washed
with 1 L of acetone, then dried in a vacuum oven at 50°C. 139 g of pure
white crystals of hydrogen sulfate of dextro-rotatory methyl-α-5-(4,5,6,7-
tetrahydro-thieno(3,2-c)pyridyl)(2-chlorophenyl)-acetate (SR 25990 C) are
thus obtained, m.p. 184°C, [α]D20=+55.10 (c=1.891 g/100 ml; methanol).
brand name
Plavix (Sanofi Aventis).
Therapeutic Function
Platelet aggregation inhibitor
General Description
Clopidogrel bisulfate (CLP) is an antiplatelet drug, which belongs to the thienopyridine class of drug.
Biochem/physiol Actions
(S)-(+)-Clopidogrel hydrogen sulfate is an antithrombotic antiplatelet agent. It specifically and irreversibly inhibits the Purinoceptor P2Y12 subtype which inhibits ADP-induced platelet aggregation. (S)-(+)-Clopidogrel hydrogen sulfate is the active isomer.
Veterinary Drugs and Treatments
Clopidogrel, a platelet aggregation inhibitor, may be useful for preventing thrombi in susceptible cats. It may also improve pelvic limb circulation in cats after a cardiogenic embolic event via a vasomodulating effect secondary to inhibition of serotonin release from platelets. Research is ongoing.
storage
Store at RT
References
[1] J. M. HERBERT. Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent[J]. Cardiovascular Therapeutics, 1993, 11 2: 180-198. DOI: 10.1111/j.1527-3466.1993.tb00275.x
Clopidogrel Bisulfate Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hebei Chuanghai Biotechnology Co., Ltd | +86-15350571055 | Sibel@chuanghaibio.com | China | 8737 | 58 |
| Hebei Yanxi Chemical Co., Ltd. | +86-17531190177 | faithe@yan-xi.com | China | 5838 | 58 |
| Henan Bao Enluo International TradeCo.，LTD | +86-17331933971 | deasea125996@gmail.com | China | 2452 | 58 |
| airuikechemical co., ltd. | +86-18353166132 | sales02@airuikechemical.com | China | 983 | 58 |
| Shaanxi TNJONE Pharmaceutical Co., Ltd | sarah@tnjone.com | China | 1139 | 58 | |
| Capot Chemical Co.,Ltd. | +86-（0）57185586718 +86-13336195806 | sales@capot.com | China | 29626 | 60 |
| Nanjing ChemLin Chemical Industry Co., Ltd. | 025-83697070 | product@chemlin.com.cn | CHINA | 3004 | 60 |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32998 | 60 |
| Tianjin Zhongxin Chemtech Co., Ltd. | 86-22-66880623 +8618622897568 | sales@tjzxchem.com | China | 571 | 58 |
| career henan chemical co | +86-0371-86658258 | sales@coreychem.com | China | 29766 | 58 |
View Lastest Price from Clopidogrel Bisulfate manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-08-07 | Clopidogrel Bisulfate
120202-66-6
|
1KG | 98.0～101.0% | 500kg/month | WUHAN FORTUNA CHEMICAL CO., LTD | ||
 |
2026-07-15 | Clopidogrel hydrogen sulfate
120202-66-6
|
$30.00-50.00 | 99.79% | 10g | TargetMol Chemicals Inc. | ||
 |
2026-07-15 | Clopidogrel hydrogen sulfate
120202-66-6
|
$30.00-50.00 | 99.79% | 10g | TargetMol Chemicals Inc. |
-
- Clopidogrel Bisulfate
120202-66-6
- $0.00
- 98.0～101.0%
- WUHAN FORTUNA CHEMICAL CO., LTD
-
- Clopidogrel hydrogen sulfate
120202-66-6
- $30.00-50.00
- 99.79%
- TargetMol Chemicals Inc.
-
- Clopidogrel hydrogen sulfate
120202-66-6
- $30.00-50.00
- 99.79%
- TargetMol Chemicals Inc.
